Compare WB & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WB | SPRC |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 4.5M |
| IPO Year | 2014 | N/A |
| Metric | WB | SPRC |
|---|---|---|
| Price | $10.59 | $1.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 864.0K | ★ 1.3M |
| Earning Date | 11-18-2025 | 03-23-2026 |
| Dividend Yield | ★ 15.56% | N/A |
| EPS Growth | ★ 20.16 | N/A |
| EPS | ★ 1.76 | N/A |
| Revenue | ★ $1,740,785,000.00 | $1,306,000.00 |
| Revenue This Year | $0.53 | N/A |
| Revenue Next Year | $2.38 | N/A |
| P/E Ratio | $6.00 | ★ N/A |
| Revenue Growth | N/A | ★ 187.98 |
| 52 Week Low | $7.10 | $1.25 |
| 52 Week High | $12.96 | $37.59 |
| Indicator | WB | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 61.73 | 33.17 |
| Support Level | $10.00 | $1.25 |
| Resistance Level | $10.29 | $1.56 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 87.50 | 19.61 |
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.